Skip to content

CAPTIA CMV-M

by Mercia Diagnostics, Ltd.

510(k) K896295

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK896295 Date6 Mar 1990ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Captia(R) Cmv-M
510(k) Number
FDA Product Code
LFZ
FDA applicant
Mercia Diagnostics , Ltd.
Device Class
Class II
Regulation
21 CFR Part 866.3175
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The CAPTIA CMV-M is an Enzyme-Linked Immunosorbent Assay (ELISA) for the qualitative detection of cytomegalovirus (CMV) IgM antibodies in human serum or plasma. This in vitro diagnostic device aids in the serological diagnosis of primary CMV infection by identifying recent or acute CMV exposure through the presence of IgM antibodies.

This device is supplied as a single-use diagnostic kit and is intended for use in clinical microbiology laboratories. It requires no special storage conditions beyond refrigeration and is not classified as MRI-safe or unsafe. The CAPTIA CMV-M has received FDA 510(k) clearance (K896295) under the Microbiology advisory committee, with a classification as a Class II device (regulation number 866.3175). It is distributed under the product code LFZ and is intended for professional laboratory use only.

Other devices from Mercia Diagnostics, Ltd.

See all devices from Mercia Diagnostics, Ltd. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the CAPTIA CMV-M used for in a clinical setting?

    The CAPTIA CMV-M is an ELISA test designed to detect cytomegalovirus (CMV) IgM antibodies in human serum or plasma. It helps identify recent or acute CMV infection by detecting IgM antibodies, which indicate primary exposure to the virus. This aids clinicians in diagnosing active CMV infections in patients.

  • Is the CAPTIA CMV-M kit meant for single-use or can it be reused?

    The CAPTIA CMV-M is explicitly supplied as a single-use diagnostic kit. Each kit is intended for one test procedure only, ensuring accuracy and preventing cross-contamination in clinical microbiology laboratories.

  • What storage conditions are required for the CAPTIA CMV-M?

    The CAPTIA CMV-M does not require any special storage conditions beyond standard refrigeration. This makes it convenient for clinical laboratories to store and maintain without additional infrastructure.

  • How is the CAPTIA CMV-M regulated in the U.S.?

    The CAPTIA CMV-M has received FDA 510(k) clearance (K896295) under the Microbiology advisory committee, classified as a Class II device (regulation number 866.3175). This means it has been determined to be substantially equivalent to a predicate device and is authorized for professional laboratory use only.

  • Can the CAPTIA CMV-M be used outside of a clinical microbiology lab?

    No, the CAPTIA CMV-M is explicitly intended for use in clinical microbiology laboratories. Its design and regulatory clearance reflect its purpose as a professional diagnostic tool, not for point-of-care or home testing.